Serum ceruloplasmin levels in acute decompensated heart failure

Clinica Terapeutica

Volumn 164, Issue 3, 2013, Pages

  Kaya, Z ^a   Kaya, B C ^a   Sezen, H ^b   Bilinc, H ^a   Asoglu, R ^a   Yildiz, A ^a   Taskin, A ^a   Yalcin, S ^a   Sezen, Y ^a   Aksoy, N ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b Sanliurfa Training and Research Hospital   (Turkey)

Author keywords

Ceruloplasmin; Oxidative stress index; Preeclampsia; Total antioxidant status; Total oxidant status

Indexed keywords

ACETYLSALICYLIC ACID; CERULOPLASMIN; DIURETIC AGENT;

ACUTE HEART FAILURE; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG USE; HEART EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; OBSERVATIONAL STUDY; SEX DIFFERENCE; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE;

ACUTE DISEASE; CERULOPLASMIN; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 84883581016     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: 10.7417/CT.2013.1558     Document Type: Article

References (21)

1. Healy J. Tipton K. Ceruloplasmin and what it might do. J Neural Transm 2007; 114:777-81
2. Viestenz KE, Klevay LM. A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency. Am J Clin Nutr 1982; 35:258-66
3. Kuan P. Cardiac Wilson's disease. Chest 1987; 91:579-83
4. Milo-Cotter O, Cotter-Davison B, et al. Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology 2011; 119:96-105
5. Singh TK. Serum ceruloplasmin in acute myocardial infarction. Acta Cardiol 1992; 47:321-9
6. Göçmen AY, Sahin E, Semiz E, et al. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease? Can J Cardiol 2008; 24:209-12
7. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. EHJ 2012; 33:1787-847
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention. Detection. Evaluation. and Treatment of High Blood Pressure (JNC-7). Hypertension 2003; 42:1206-52
9. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard. comprehensive and minimal care. Diabet Med 2006; 23:579-93
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-421
11. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998; 44:2313-9
12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Biochem 2004; 37:112-9
13. Schiller NB. Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-67
14. Schiller NB, Acquatella H, Ports TA, et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 1979; 60:547-55
15. Holmberg CG, Laurell C-B. Investigations in serum copper. II. Isolation of the Copper containing protein, and a description of its properties. Acta Chem Scand 1948; 2:550-6
16. Brunetti ND, Pellegrino PL, Correale M, et al. Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction. J Thromb Thrombolysis 2008; 26: 196-202
17. Charniot JC, Vignat N, Albertini JP, et al. Oxidative stress in patients with acute heart failure. Rejuvenation Res 2008; 11:393-8
18. Wang G, Hamid T, Keith RJ, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010; 121:1912-9
19. Bhimaraj A, Tang WH. Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure. Heart Fail Clin 2012; 8:101-11
20. Bergamini C, Cicoira M, Rossi A, et al. Oxidative stress and hyperuricaemia: pathophysiology. clinical relevance. and therapeutic implications in chronic heart failure. Eur J Heart Fail 2009; 11:444-52
21. Kunishige M, Kijima Y, Sakai T, et al. Transient enhancement of oxidant stress and collagen turnover in patients with acute worsening of congestive heart failure. Circ J 2007; 71: 1893-7